Royce Micro-Cap Trust (RMT) was incepted in Dec. 1993 as a perpetual equity closed-end fund. The Fund's investment goal is long-term capital growth, which it seeks by investing primarily in equity ...

EVI Industries Inc. (NYSEAMERICAN:EVI) is one of the most promising micro-cap stocks according to analysts. On February 9, EVI Industries reported results for FQ2 2026, with revenue jumping 24% to ...

In this article, we will be taking a look at the 12 Penny Stocks with Insider Buying in 2026. The CEO of Wealth Consulting ...

While the Wasatch Micro Cap Fund—Investor Class posted a double-digit return of 12.61%, performance relative to the benchmark Russell Microcap® Growth Index, which gained 20.92%, was constrained by ...

All performance information reflects past performance, is presented on a total return basis, net of the Fund's investment advisory fee, and reflects the reinvestment of distributions. Past performance ...

[With over two decades of underperformance to their larger brethren, small-cap and micro-cap stocks are due for a deep dive review and reappraisal. This divergent performance has created significant ...

Kara Greenberg is a senior news editor for Investopedia, where she does work writing, editing, and assigning daily markets and investing news. Prior to joining Investopedia, Kara was a researcher and ...

As 2025 approaches, several promising micro-cap stocks are gaining attention for their potential to disrupt key industries. These companies, though small in market size, are making significant strides ...

Joseph Lucosky is the Managing Partner of Lucosky Brookman, a leading law firm in the world of microcap IPOs and Nasdaq/NYSE listings. On the surface, the 2025 micro-cap IPO market was more active ...

Few stocks have ridden the coattails of the artificial intelligence boom like Super Micro Computer. It has been a wild ride for the company and small- and mid-cap stock funds, though, whether or not ...

Spruce Biosciences Inc. (NASDAQ:SPRB) is one of the most promising micro-cap stocks according to analysts. On February 18, Spruce Biosciences recently concluded successful Type B meetings with the FDA ...